Galapagos NV
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
13 jan 2014 - 07:40
Statutory name
Galapagos NV
Title
Galapagos receives €2.9 million IWT grant for cystic fibrosis research
Comments
Mechelen, Belgium; 13 January 2014 - Galapagos NV (Euronext: GLPG) announced today that it has been awarded a €2.9 million grant from the Flemish agency for Innovation by Science and Technology (IWT) for cystic fibrosis (CF) research. The goal of this 3-year project is to identify and progress multiple promising CF therapies towards pre-clinical candidates.